Resveratrol Loaded Liposomes Disrupt Cancer Associated Fibroblast Communications within the Tumor Microenvironment to Inhibit Colorectal Cancer Aggressiveness

Resveratrol Loaded Liposomes Disrupt Cancer Associated Fibroblast Communications within the Tumor Microenvironment to Inhibit Colorectal Cancer Aggressiveness

Colorectal cancer (CRC) is a cancer-associated fibroblast, CAF-rich tumor. CAF promotes cancer cell proliferation, metastasis, drug resistance via secretes soluble factors, and extracellular matrices which leads to dense stroma, a major barrier for drug delivery. Resveratrol (RES) is a polyphenolic...

Full description

Bibliographic Details
Main Authors:	Paweena Dana, Nutthanit Thumrongsiri, Prattana Tanyapanyachon, Walailuk Chonniyom, Primana Punnakitikashem, Nattika Saengkrit
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Nanomaterials
Subjects:	resveratrol colorectal cancer cancer associated fibroblast metastasis drug sensitivity liposome
Online Access:	https://www.mdpi.com/2079-4991/13/1/107

Similar Items

Enhancing in Vitro anti-metastatic efficacy and deep penetration into tumor spheroid of docetaxel-loaded liposomes via size optimization for prostate cancer treatment
by: Saksorn Klibaim, et al.
Published: (2025-03-01)

Alginate-based encapsulation of porcine placenta extract: Preparation, enteric sustained release, biological activities, and stability
by: Anukul Taweechaipaisankul, et al.
Published: (2025-06-01)

Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy
by: Paweena Dana, et al.
Published: (2022-07-01)

Nanoformulation, characterization, and biological activity assays of extracts of Derris trifoliata Lour, a rutin-rich mangrove plant
by: Prattana Tanyapanyachon, et al.
Published: (2025-03-01)

Enhanced Subcellular Trafficking of Resveratrol Using Mitochondriotropic Liposomes in Cancer Cells
by: Ji Hee Kang, et al.
Published: (2019-08-01)

Enhanced biological activity of liposomal methylated resveratrol analog 3′-hydroxy-3,4,5,4′-tetramethoxystilbene (DMU-214) in 3D patient-derived ovarian cancer model
by: Andrzej Nowicki, et al.
Published: (2022-12-01)

Resveratrol-Loaded Glycosylated Liposomes for Targeting Bacteria
by: Cecilia Bombelli, et al.
Published: (2022-11-01)

Remodeling immune microenvironment in periodontitis using resveratrol liposomes as an antibiotic-free therapeutic strategy
by: Junyu Shi, et al.
Published: (2021-12-01)

Liposomes-In-Hydrogel Delivery System Enhances the Potential of Resveratrol in Combating Vaginal Chlamydia Infection
by: May Wenche Jøraholmen, et al.
Published: (2020-12-01)

Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions
by: Lolita Kursvietiene, et al.
Published: (2023-11-01)

Proliferative and Anti-Inflammatory Effects of Resveratrol and Silymarin on Human Gingival Fibroblasts: A View to the Future
by: Minoo Shahidi, et al.
Published: (2017-10-01)

Resveratrol in Cancer Prevention and Treatment: Focusing on Molecular Targets and Mechanism of Action
by: Adriana Borriello
Published: (2017-11-01)

Insights on the Effects of Resveratrol and Some of Its Derivatives in Cancer and Autoimmunity: A Molecule with a Dual Activity
by: Elena Gianchecchi, et al.
Published: (2020-01-01)

Impact of resveratrol-loaded liposomal nanocarriers on heat-stressed broiler chickens: Effects on performance, sirtuin expression, oxidative stress regulators, and muscle building factors
by: Asmaa T. Y. Kishawy, et al.
Published: (2023-03-01)

Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer
by: Sandra Cotino-Nájera, et al.
Published: (2023-11-01)

Pterostilbene Suppresses both Cancer Cells and Cancer Stem-Like Cells in Cervical Cancer with Superior Bioavailability to Resveratrol
by: Hee Jeong Shin, et al.
Published: (2020-01-01)

A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial–mesenchymal transition reversion
by: Jian Guo, et al.
Published: (2022-03-01)

Toxicity Assessment of Resveratrol Liposomes-in-Hydrogel Delivery System by EpiVaginal<sup>TM</sup> Tissue Model
by: May Wenche Jøraholmen, et al.
Published: (2022-06-01)

Liposomic nano particles in the treatment of colorectal and ovarian cancer
by: Sheikh Rezzak Ali, et al.
Published: (2024-08-01)

Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/STAT3 Pathway
by: Zhu WT, et al.
Published: (2023-05-01)

Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy
by: Zhaohuan Li, et al.
Published: (2021-12-01)

The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment
by: Natalie Silk, et al.
Published: (2021-02-01)

The Plant-Derived Compound Resveratrol in Brain Cancer: A Review
by: Terezia Kiskova, et al.
Published: (2020-01-01)

Resveratrol and Resveratrol-Loaded Galactosylated Liposomes: Anti-Adherence and Cell Wall Damage Effects on <i>Staphylococcus aureus</i> and MRSA
by: Giuliana Prevete, et al.
Published: (2023-12-01)

Resveratrol Targets a Variety of Oncogenic and Oncosuppressive Signaling for Ovarian Cancer Prevention and Treatment
by: Xue-Ling Xu, et al.
Published: (2021-10-01)

Development and Evaluation of AT11-Guided Liposomes for Human Papillomavirus Cancer
by: Jéssica Lopes-Nunes, et al.
Published: (2022-11-01)

Liposomal Nanocarriers to Enhance Skin Delivery of Chemotherapeutics in Cancer Therapy
by: Xiangli Liu, et al.
Published: (2025-01-01)

Resveratrol, a food-derived polyphenol, promotes Melanosomal degradation in skin fibroblasts through coordinated activation of autophagy, lysosomal, and antioxidant pathways
by: Saki Okamoto, et al.
Published: (2025-02-01)

Potential role of resveratrol and its nano-formulation as anti-cancer agent
by: Akshay Kumar, et al.
Published: (2022-10-01)

Development of cancer-associated fibroblasts-targeting polymeric nanoparticles loaded with 8-O-methylfusarubin for breast cancer treatment
by: Kamonlatth Rodponthukwaji, et al.
Published: (2024-12-01)

Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer
by: Jasmine S. Owen, et al.
Published: (2022-12-01)

Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment
by: Hung-Jun Lin, et al.
Published: (2022-06-01)

Editorial: Role of fibroblast in cancer
by: Xuezhen Zeng, et al.
Published: (2025-02-01)

Resveratrol Analog 4-Bromo-Resveratrol Inhibits Gastric Cancer Stemness through the SIRT3-c-Jun N-Terminal Kinase Signaling Pathway
by: Yun-Shen Tai, et al.
Published: (2021-12-01)

Liposomes for the treatment of prostate cancer therapy: A review
by: Chinmaya Keshari Sahoo, et al.
Published: (2024-01-01)

Investigating the therapeutic effect of doxorubicin and resveratrol on MCF7 breast cancer cells
by: Shima Zorati pour, et al.
Published: (2023-09-01)

The Anti-Cancer Effects of Mitochondrial-Targeted Triphenylphosphonium–Resveratrol Conjugate on Breast Cancer Cells
by: Lingling Jiang, et al.
Published: (2022-10-01)

The anti‐cancer effect of chitosan/resveratrol polymeric nanocomplex against triple‐negative breast cancer; an in vitro assessment
by: Azam Bozorgi, et al.
Published: (2023-04-01)

The Use of Micro- and Nanocarriers for Resveratrol Delivery into and across the Skin in Different Skin Diseases—A Literature Review
by: Beata Szulc-Musioł, et al.
Published: (2021-03-01)

Potential of Resveratrol to Combine with Hydrogel for Photodynamic Therapy against Bacteria and Cancer—A Review
by: Siu Kan Law, et al.
Published: (2024-09-01)